Obesity in Polycystic Ovary Syndrome: Insulin Sensitizing Therapy-Reference-Cited by-同舟云学术

Obesity in Polycystic Ovary Syndrome: Insulin Sensitizing Therapy

Published:2012-08-19 Issue:4 Volume:1 Page:191-198
ISSN:2162-4968
Container-title:Current Obesity Reports
language:en
Short-container-title:Curr Obes Rep

Author:

Hoeger Kathleen M.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13679-012-0030-y.pdf

Reference79 articles.

1. Stein IF ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181–191.

2. The ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.

3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.

4. Carmina E. Genetic and environmental aspect of polycystic ovary syndrome. J Endocrinol Invest. 2003;26:1151–9.

5. Freedman DS. Obesity - United States, 1988–2008. MMWR Surveill Summ. 2011;60(Suppl):73–7.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study;Journal of Human Reproductive Sciences;2024-01

2. Ficus deltoidea ameliorates biochemical, hormonal, and histomorphometric changes in letrozole-induced polycystic ovarian syndrome rats;BMC Complementary Medicine and Therapies;2021-11-29